Kiora Pharmaceuticals Statistics
Total Valuation
KPRX has a market cap or net worth of $11.06 million. The enterprise value is -$5.66 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, before market open.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KPRX has 4.39 million shares outstanding. The number of shares has increased by 1.01% in one year.
| Current Share Class | 4.39M |
| Shares Outstanding | 4.39M |
| Shares Change (YoY) | +1.01% |
| Shares Change (QoQ) | -4.39% |
| Owned by Insiders (%) | 3.08% |
| Owned by Institutions (%) | 19.02% |
| Float | 4.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.99, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.99 |
| Quick Ratio | 5.62 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -473.91 |
Financial Efficiency
Return on equity (ROE) is -51.74% and return on invested capital (ROIC) is -664.93%.
| Return on Equity (ROE) | -51.74% |
| Return on Assets (ROA) | -19.47% |
| Return on Invested Capital (ROIC) | -664.93% |
| Return on Capital Employed (ROCE) | -45.87% |
| Weighted Average Cost of Capital (WACC) | 0.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$902,930 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.36% in the last 52 weeks. The beta is -0.77, so KPRX's price volatility has been lower than the market average.
| Beta (5Y) | -0.77 |
| 52-Week Price Change | -8.36% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 61.71 |
| Average Volume (20 Days) | 1,437,030 |
Short Selling Information
The latest short interest is 16,951, so 0.39% of the outstanding shares have been sold short.
| Short Interest | 16,951 |
| Short Previous Month | 15,786 |
| Short % of Shares Out | 0.39% |
| Short % of Float | 0.40% |
| Short Ratio (days to cover) | 0.54 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.71M |
| Operating Income | -9.46M |
| Pretax Income | -12.12M |
| Net Income | -10.84M |
| EBITDA | -9.43M |
| EBIT | -9.46M |
| Earnings Per Share (EPS) | -$2.64 |
Full Income StatementBalance Sheet
The company has $17.09 million in cash and $368,259 in debt, with a net cash position of $16.72 million or $3.81 per share.
| Cash & Cash Equivalents | 17.09M |
| Total Debt | 368,259 |
| Net Cash | 16.72M |
| Net Cash Per Share | $3.81 |
| Equity (Book Value) | 16.13M |
| Book Value Per Share | 4.29 |
| Working Capital | 18.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.96 million and capital expenditures -$110,789, giving a free cash flow of -$10.07 million.
| Operating Cash Flow | -9.96M |
| Capital Expenditures | -110,789 |
| Depreciation & Amortization | 24,801 |
| Net Borrowing | n/a |
| Free Cash Flow | -10.07M |
| FCF Per Share | -$2.29 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.01% |
| Shareholder Yield | -1.01% |
| Earnings Yield | -97.96% |
| FCF Yield | -91.06% |
Analyst Forecast
The average price target for KPRX is $10.00, which is 296.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 296.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2024. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jun 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
